Skip to main content
    G

    Grifols SA ADR (GRFS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $8.73
    +0.04 (+0.46%)

    Market Cap: $5.91B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Grifols SA ADR (GRFS) P/E Ratio & Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Grifols SA ADR (GRFS) trades at 9.9x trailing earnings and 0.7x sales. Its P/S of 0.7x is below its 5-year median of 0.8x. Its forward P/E is 7.3x. The median P/E across 7 similar companies is 21.4x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 35.6% higher over the next year. Its free cash flow yield is 14.5%.

    MultipleValue
    P/E (trailing)9.9x
    Forward P/E7.3x
    Price to sales0.7x
    Price to book0.9x
    EV/EBITDA7.5x
    Price to FCF6.9x
    EV/FCF18.4x
    PEG0.2
    FCF yield14.5%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 56.3% below 1.6x and its P/B is 47.1% below 1.7x.

    MultipleCurrent5-year median10-year median
    P/S0.7x0.8x1.6x
    P/B0.9x0.9x1.7x
    Medians of month-end values through Oct 2026: 52 to 60 months (5-year) and 111 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 0.7x in 2024 to 3.2x in 2017.

    Year endPriceP/SP/B
    2025$9.350.7x1.0x
    2024$7.440.7x0.8x
    2023$11.561.1x1.2x
    2022$8.500.9x0.9x
    2021$11.231.2x1.2x
    2020$18.441.8x2.0x
    2019$23.292.8x2.5x
    2018$18.362.4x2.6x
    2017$22.923.2x3.6x
    2016$16.072.5x2.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    P/E history is shown only for companies that report in US dollars.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About GRFS

    What is GRFS's forward P/E ratio?

    Grifols SA ADR has a forward P/E ratio of 7.3x.

    Is GRFS stock overvalued?

    GNG's valuation label for GRFS is Undervalued. Its P/E of 9.9x compares with a median of 21.4x across 7 similar companies.

    What is GRFS's price to sales ratio?

    Grifols SA ADR has a price to sales ratio of 0.7x.

    What is GRFS's PEG ratio?

    Grifols SA ADR has a PEG ratio of 0.2.